Stay updated on Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial page.

Latest updates to the Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial page
- Check6 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check13 days agoChange DetectedA site-wide notice about NIH website changes and the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page content.SummaryDifference1%

- Check20 days agoChange DetectedThe footer now displays site revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check27 days agoChange DetectedThe page remains a 403 Forbidden error page, with the displayed site revision changing from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check48 days agoChange DetectedThe PATHFNDR-1 study page now shows a 403 Forbidden error, and the detailed study content and documents are no longer visible on the page.SummaryDifference18%

- Check69 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a minor page version update. This typically reflects maintenance or fixes and does not indicate changes to the study details shown on the page.SummaryDifference0.0%

Stay in the know with updates to Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial page.